NEWS
NEWS
Big Pharma’s Bets: Where They’re Investing And Acquiring Across Biotech, Drug Delivery, And More
Johnson & Johnson is the only big pharma company in the top three for both financing and M&A. The pharmaceutical industry is undergoing a...
Want a glimpse into pharma’s future? Look to cable television, Merck CEO says
If all the scrutiny on drug prices has taught us anything, it's that there are a lot of intermediate players in today’s pharma supply chain. But...
UK public-private partnership to use AI to cut drug failure rate
Author: Richard Staines A UK R&D project has secured a government grant to help its artificial intelligence (AI)-based drug discovery...
Takeda blesses a little biotech’s engineered toxin tech for multiple myeloma, triggering a bases loaded home run
Author: John Carroll You need a license to cut-and-paste this copyrighted news content. Use this link to purchase your paid subscription...
Mylan, Fujifilm score EU thumbs-up for Humira biosimilar, putting more pressure on AbbVie
AbbVie and its investors have been fretting over the potential impact of biosimilar competition to Humira—the world’s top-selling drug, with more...
LATEST NEWS
Bulgaria resumes the “green corridor” walk-in vaccination scheme
30,000 Bulgarians receive jabs against Covid-19 in last three days
CureVac’s mRNA coronavirus shot boasts one advantage over Pfizer and Moderna counterparts—refrigerated storage
COVID-19 vaccine players will split $100B in sales and $40B in profits, with Moderna leading the way: analyst
More Than Half of Doctors Now Part of Healthcare Systems
NEWS
Big Pharma’s Bets: Where They’re Investing And Acquiring Across Biotech, Drug Delivery, And More
Johnson & Johnson is the only big pharma company in the top three for both financing and M&A. The pharmaceutical industry is undergoing a...
Want a glimpse into pharma’s future? Look to cable television, Merck CEO says
If all the scrutiny on drug prices has taught us anything, it's that there are a lot of intermediate players in today’s pharma supply chain. But...
UK public-private partnership to use AI to cut drug failure rate
Author: Richard Staines A UK R&D project has secured a government grant to help its artificial intelligence (AI)-based drug discovery...
Takeda blesses a little biotech’s engineered toxin tech for multiple myeloma, triggering a bases loaded home run
Author: John Carroll You need a license to cut-and-paste this copyrighted news content. Use this link to purchase your paid subscription...
Mylan, Fujifilm score EU thumbs-up for Humira biosimilar, putting more pressure on AbbVie
AbbVie and its investors have been fretting over the potential impact of biosimilar competition to Humira—the world’s top-selling drug, with more...
LATEST NEWS
Bulgaria resumes the “green corridor” walk-in vaccination scheme
30,000 Bulgarians receive jabs against Covid-19 in last three days
CureVac’s mRNA coronavirus shot boasts one advantage over Pfizer and Moderna counterparts—refrigerated storage
COVID-19 vaccine players will split $100B in sales and $40B in profits, with Moderna leading the way: analyst
More Than Half of Doctors Now Part of Healthcare Systems